Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RBR-8vsb7k2Phase 4Completed
Phase 4, randomised, double-blind trial in cancer comparing Omeprazole add-on with Placebo control (2 arms). Primary endpoints: Change in intraerythrocyte magnesium concentration and Change in serum magnesium concentration. Started May 2019; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on RBR-8vsb7k2.